Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk
about
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexLung carcinogenesis by tobacco smokeThe Oncogenic Functions of Nicotinic Acetylcholine ReceptorsPharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6From men to mice: CHRNA5/CHRNA3, smoking behavior and diseaseNicotinic receptor modulation to treat alcohol and drug dependenceNovel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer RiskContribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.Resting-state functional connectivity and nicotine addiction: prospects for biomarker developmentPredictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.Interaction between cytochrome P450 2A6 and Catechol-O-Methyltransferase genes and their association with smoking risk in young men."Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort studyPrecision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioNicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokersGenetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseasesFinding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysisKnown and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersNicotine: specific role in angiogenesis, proliferation and apoptosis.Comparative study of seven commercial kits for human DNA extraction from urine samples suitable for DNA biomarker-based public health studies.Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.Pharmacogenetic Optimization of Smoking Cessation Treatment.A DRD1 polymorphism predisposes to lung cancer among those exposed to secondhand smoke during childhood.Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis.CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populationsThe contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populationsUGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.CHRNA3 rs6495308 genotype as an effect modifier of the association between daily cigarette consumption and hypertension in Chinese male smokers.Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline SmokingGene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotineCYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native peopleDRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.Reproducibility of the nicotine metabolite ratio in cigarette smokers.Views on electronic cigarette use in tobacco screening and cessation in an Alaska Native healthcare settingThe role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15.Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers
P2860
Q24595571-4D1C1A43-B13B-4425-A362-24571DFC8993Q24625044-4A22BB4C-7228-428D-9E8D-3A65A6266C57Q26765286-A4E8E417-6447-4735-AB92-307D5955A4A2Q27012807-225B1B17-72FE-4CCF-8B6B-EC641395A38CQ27021102-FBAC31A1-5D1F-42D1-9206-352DC2ADF2AAQ28087047-6FDE1CE9-A9BD-4845-900D-BC3DA48DA246Q28390824-241DEABD-D372-42D2-BEA1-9966FEE06B3AQ30301171-75C4252E-2D38-4A7F-AA1F-4E6FD463C7D1Q30992161-37FD83BA-50EA-444F-86D6-3D38C97812E0Q33458739-EB28E838-2C95-4CA8-92E4-F80A82F4D521Q33640705-D497B0BD-286E-4253-961F-D4A9AE8412E7Q33651168-27B94156-4190-4F13-9743-9BBF2647A645Q33728649-77E8B161-E793-4A90-BDD4-56594ADD28D8Q33821233-37FBF548-12E3-4C04-9886-CAF94CE4A6CAQ33893086-4196A1DE-595A-4EF9-9EDE-32BE5FBC86A1Q33915416-3034CA04-FB24-4E19-AD9E-118BA2931BA0Q33953232-1C82E723-D1F2-4174-B66F-C2695F232D87Q33959432-82F8674F-19C3-4E17-AAF1-5255CF5A7B9FQ33983933-4736459F-A0E0-4C53-B8D6-73BE074C06CEQ34135377-19C04E6B-F137-4886-AB29-740E8D173288Q34229828-A15A1A53-54CE-4A21-BC3E-E0A36288C2BEQ34305390-688CBDED-3B79-4845-A6CA-6E3F871E7E5EQ34307589-A4AEE394-5E9F-4005-9C58-AB4CDE261AE6Q34434951-D432BFBE-61E7-4E09-BDEA-D19CFFDBED8BQ34542169-CE81BBB6-F503-49CF-BAE3-1C5D67370A87Q34633132-CD2BD342-6EC0-4BA2-9EE8-081EED587E03Q34667734-FE51509E-0699-4232-A7AF-FC1A16F84DE5Q34918092-6D67E814-DCB1-44FD-A488-BAAF51976C66Q34963910-B581093E-9662-4F37-A327-07113635DFE6Q34964392-9DE933E8-C3DA-457F-94FD-05FAF97DE9B3Q35539835-D8DB9DE8-7EA9-4DDD-99ED-E1646A0BD2F0Q35641707-7E8B2855-BA1A-41BE-A34F-86B4A07463B7Q35686543-AB48B9B4-4147-4C5B-B3EA-75CE7DE9436AQ35892758-31EE283A-AD9E-408C-8E2F-C86EB423CD06Q35949266-CA0297A1-CA9D-4CB5-ACD5-9FA9F6EF4E6AQ36035320-F4B1E275-2EC2-4E90-8EF8-A79DC24834F6Q36084196-92D33DE2-1726-41F4-919C-2B234F108629Q36181685-84B8F01D-DF0E-4626-86A7-412102FDA493Q36255637-C729BB39-FDE7-4D19-A137-9CB04F99513BQ36303865-1C90D4C4-EA8A-4330-966C-51D3832DBDE9
P2860
Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@ast
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@en
type
label
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@ast
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@en
prefLabel
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@ast
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@en
P2093
P2860
P50
P356
P1476
Relationship between CYP2A6 an ...... behaviors and lung cancer risk
@en
P2093
Catherine A Wassenaar
Qingyi Wei
Qiong Dong
P2860
P304
P356
10.1093/JNCI/DJR237
P407
P577
2011-07-11T00:00:00Z